Last reviewed · How we verify

Application of Tachosil During Lymphadenectomy

NCT03752606 PHASE4 COMPLETED

The prevention of lymphoceles was assessed using collagen patch coated with the human coagulation factors (TachoSil, Nycomed International Management GmbH, Zurich, Switzerland; NCT Number ICMJE NCT01192022; Other Study ID Numbers ICMJE TC-2402-040-SP; U1111-1130-9121 Registry Identifier: WHO) on 50 consecutive patients with endometrial and cervical cancer stages IB to II who had undergone open hysterectomy and pelvic lymphadenectomy (PL). Methods: Each patient was simultaneously randomized in two groups: as a control (side without Tachosil applied) and study group (side with Tachosil applied). All surgical parameters were collected and patients underwent ultrasound examination on postoperative days 1, 6, and 30, and at the end of treatment.

Details

Lead sponsorMedical University of Lublin
PhasePHASE4
StatusCOMPLETED
Enrolment50
Start dateFri Nov 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionSun Dec 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

Poland